RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -23.89M | -11.61M | -18.32M | -14.45M | -12.11M |
| Total Depreciation and Amortization | 94.00K | 93.00K | 100.00K | 95.00K | 91.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 1.13M | 968.00K |
| Total Other Non-Cash Items | 14.19M | 4.89M | 6.17M | -916.00K | -4.49M |
| Change in Net Operating Assets | -2.46M | 813.00K | -4.39M | 4.04M | 17.53M |
| Cash from Operations | -12.06M | -5.82M | -16.43M | -10.10M | 2.00M |
| Capital Expenditure | -1.05M | -1.30M | -700.00K | -25.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 87.00K | 79.00K | 528.00K | 256.00K | 57.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -959.00K | -1.23M | -172.00K | 231.00K | 57.00K |
| Total Debt Issued | -- | -- | 1.72M | 19.09M | -- |
| Total Debt Repaid | -443.00K | -4.88M | -294.00K | -609.00K | -907.00K |
| Issuance of Common Stock | 0.00 | 92.00K | -- | 23.73M | 0.00 |
| Repurchase of Common Stock | -17.00K | -72.00K | -30.00K | -3.00K | -74.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -460.00K | -4.86M | 1.40M | 42.21M | -981.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.48M | -11.90M | -15.21M | 32.34M | 1.07M |